Evidence map›Paper›PMID 32078106›Full record

ArticleInternational journal of clinical pharmacy2020

Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients.

Rashida Muhammad Umar, Sule Apikoglu-Rabus, Perran Fulden Yumuk

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Proactive risk assessment and nursing risk management in chemotherapy drugs: FMECA methodology results.Journal of healthcare risk management : the journal of the American Society for Healthcare Risk Management · 2026
    Article
  5. Medication regimen complexity in cancer patients: an overlooked issue for healthcare team.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung Cancer.Journal of the National Comprehensive Cancer Network : JNCCN · 2023
    Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Impact of Clinical Pharmacist-led Interventions in TurkeyTurkish journal of pharmaceutical sciences · 2021
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rashida Muhammad Umar *Clinical Pharmacy Department, Istanbul Medipol University Faculty of Pharmacy, Istanbul, Turkey. rmumar@medipol.edu.tr.ORCID http://orcid.org/0000-0001-8902-7274
Sule Apikoglu-Rabus *Clinical Pharmacy Department, Marmara University Faculty of Pharmacy, Istanbul, Turkey.
Perran Fulden YumukDivision of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The use of highly toxic drugs in cancer treatment and supportive care medications exposes patients to an increased number of drug-related problems (DRPs). Clinical pharmacists contribute to the optimal use of medications by intervening in identified drug-related problems. Objective To evaluate the relevance of a comprehensive medication management service in oncology patients. Setting Marmara University Teaching and Research Hospital Medical Oncology Ward, Istanbul, Turkey. Methods This prospective study was carried out between December 2015 and April 2016 with adult patients with confirmed malignancy. Comprehensive medication management was performed by the clinical pharmacist throughout the patient's hospital stay. The medication-related data as well as data regarding demographic and general health status of the patients were reviewed for the presence of drug-related problems. The identified problems, interventions and acceptance rate by physicians were recorded with the help of the Pharmaceutical Care Network Europe V6.0 (PCNE) classification. Main outcome measures Number and causes of drug-related problems, nature and acceptance rate of clinical pharmacist interventions and rate of problems solved. Results The study included 137 patients. The mean (SD) age of the patients was 58 (14.6) years. A total of 481 drug-related problems were recorded. The most frequent drug-related problems were 'adverse drug events [including drug interactions]' (n = 376), 'untreated indications' (n = 59) and 'unnecessary drug treatment' (n = 25). Inappropriate combination of drugs was the cause of 73.2% of the total problems. Interventions were made to stop administration of a suitable drug if the combination with another drug was contraindicated while prescribers were mostly informed about major drug interactions. The prescribers approved 93% of the total intervention proposals. The majority (90.9%) of the identified problems were totally solved. Conclusion Integration of clinical pharmacy services through a comprehensive medication management program in oncology will help to reduce the number of drug-related problems.

Indexed as

AdultAgedAged, 80 and overAntineoplastic AgentsCohort StudiesDrug InteractionsDrug-Related Side Effects and Adverse ReactionsFemaleHumansMaleMedical OncologyMedication ErrorsMedication Therapy ManagementMiddle AgedNeoplasmsPharmacistsAntineoplastic AgentsClinical pharmacistDrug-related problemsMedication managementOncologyTurkey

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.